Onward Medical N.V.
Develops neurostimulation therapies to restore function for people with spinal cord injury.
ONWD | AS
Overview
Corporate Details
- ISIN(s):
- NL0015000HT4
- LEI:
- 9845007A2CC4C8BFSB80
- Country:
- Netherlands
- Address:
- Schimmelt 2, 5611ZX Eindhoven
- Website:
- https://www.onwd.com/
- Sector:
- Manufacturing
Description
Onward Medical is a neurotechnology company that develops therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's commercial product, the ARC-EX System, is an external, non-invasive spinal cord stimulation therapy indicated to improve hand sensation and strength for individuals with chronic cervical SCI. The system is used in rehabilitation clinics and is also cleared for home use. Onward Medical is also advancing its investigational implantable platform, the ARC-IM System, which is designed to address other functional deficits, including blood pressure regulation, following spinal cord injury.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-24 08:17 |
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientif…
|
English | 188.7 KB | ||
| 2025-11-17 11:38 |
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication…
|
English | 194.9 KB | ||
| 2025-10-29 07:43 |
ONWARD Medical Publishes Closing of Bookbuild Offering
|
English | 170.7 KB | ||
| 2025-10-28 17:45 |
ONWARD Medical Publishes Closing of Bookbuild Offering
|
English | 170.7 KB | ||
| 2025-10-24 12:00 |
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
|
English | 199.1 KB | ||
| 2025-10-23 06:32 |
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
|
English | 196.8 KB | ||
| 2025-10-17 07:30 |
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
|
English | 199.1 KB | ||
| 2025-10-13 07:46 |
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating AR…
|
English | 181.2 KB | ||
| 2025-10-13 07:30 |
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating AR…
|
English | 181.2 KB | ||
| 2025-09-18 08:40 |
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blo…
|
English | 205.3 KB | ||
| 2025-09-18 07:30 |
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blo…
|
English | 205.3 KB | ||
| 2025-09-08 08:59 |
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Break…
|
English | 175.6 KB | ||
| 2025-09-02 08:23 |
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the Fi…
|
English | 208.1 KB | ||
| 2025-09-02 07:42 |
ONWARD Medical N.V., Halfjaarlijkse financiële verslaggeving
|
English | 8.8 MB | ||
| 2025-09-02 07:30 |
ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the Fi…
|
English | 208.1 KB |
Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Onward Medical N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-19 | G.R. Courtine | Non-Executive member | Other | 451,822 | N/A |
| 2023-01-03 | D.L. Marver | Non-Executive member | Other | 385,000 | N/A |
| 2022-12-23 | F.A. Colen | Non-Executive member | Other | 47,740 | N/A |
| 2022-11-18 | D.L. Marver | Non-Executive member | Other | 954,814 | N/A |
| 2022-09-29 | V.E. Riefberg | Non-Executive member | Other | 16,000 | N/A |
| 2021-12-15 | J.K. Ohrstrom | Non-Executive member | Other | 38,000 | N/A |
| 2021-10-22 | D.L. Marver | Non-Executive member | Other | 6,765 | N/A |
Peer Companies
